title: Comparable attenuation of Abeta(25-35)-induced neurotoxicity by quercitrin and 17beta-estradiol in cultured rat hippocampal neurons.
abstract: In the present work, potential protective effects of quercitrin (a phytoestrogen) on Abeta-induced neurotoxicity in cultured rat hippocampal neurons were investigated in comparison with 17beta-estradiol. Cell viability, oxidative status, and antioxidative potentials were used as comparative parameters. Co-exposure of cultured neurons to Abeta(25-35) with either quercitrin or 17beta-estradiol (50-100 microM) for 72 h attenuated Abeta(25-35)-induced neurotoxicity and lipid peroxidation, but not Abeta(25-35)-induced ROS accumulation. However, only 17beta-estradiol counteracted a reduction in glutathione content and only quercitrin counteracted a reduction in glutathione peroxidase activity. Both compounds displayed no effects on superoxide dismutase activity. A specific estrogen receptor antagonist, ICI 182780, did not abolish neuroprotective effects of quercitrin and 17beta-estradiol. These findings suggested that quercitrin and 17beta-estradiol attenuated Abeta(25-35)-induced neurotoxicity in a comparable manner. Underlying neuroprotective mechanisms of both compounds were probably not related to estrogen receptor-mediated genomic mechanisms but might involve with their antioxidant and free radical scavenging properties.
authors.affiliation: Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
authors.forename: Sadudee
authors.initials: S
authors.lastname: Rattanajarasroj
authors.forename: Surachai
authors.initials: S
authors.lastname: Unchern
mesh_terms: D016229:Amyloid beta-Peptides / Q000502:physiology* / Q000633:toxicity; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004958:Estradiol / Q000494:pharmacology*; D004967:Estrogens / Q000494:pharmacology*; D016166:Free Radical Scavengers / Q000494:pharmacology; D005978:Glutathione / Q000378:metabolism; D005979:Glutathione Peroxidase / Q000378:metabolism; D006624:Hippocampus / Q000166:cytology / Q000187:drug effects*; D015227:Lipid Peroxidation / Q000187:drug effects; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D018696:Neuroprotective Agents / Q000494:pharmacology*; D010446:Peptide Fragments / Q000502:physiology* / Q000633:toxicity; D048789:Phytoestrogens / Q000494:pharmacology; D011794:Quercetin / Q000494:pharmacology*; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism; D011960:Receptors, Estrogen / Q000502:physiology; D013482:Superoxide Dismutase / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D000975:Antioxidants; D004967:Estrogens; D016166:Free Radical Scavengers; D018696:Neuroprotective Agents; D010446:Peptide Fragments; D048789:Phytoestrogens; D017382:Reactive Oxygen Species; D011960:Receptors, Estrogen; C074636:amyloid beta-protein (25-35); D004958:Estradiol; D011794:Quercetin; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase; D005978:Glutathione
references.citation: Toxicology. 2009 Apr 28;258(2-3):164-75
references.pmid: 19428936
references.citation: J Biochem. 2004 Oct;136(4):457-62
references.pmid: 15625314
references.citation: Neurochem Res. 2009 Feb;34(2):295-303
references.pmid: 18686032
references.citation: J Clin Invest. 2005 Oct;115(10):2656-64
references.pmid: 16200199
references.citation: Mol Pharmacol. 1997 Apr;51(4):535-41
references.pmid: 9106616
references.citation: Neurosci Lett. 2000 Jun 9;286(3):155-8
references.pmid: 10832008
references.citation: J Biol Chem. 2001 Feb 16;276(7):5287-95
references.pmid: 11083861
references.citation: J Neurosci Res. 1999 Aug 1;57(3):399-404
references.pmid: 10412031
references.citation: Brain Res. 2005 Nov 9;1061(2):114-7
references.pmid: 16256963
references.citation: J Korean Med Sci. 2000 Jun;15(3):327-36
references.pmid: 10895977
references.citation: Free Radic Biol Med. 2002 Jun 1;32(11):1050-60
references.pmid: 12031889
references.citation: J Neurosci. 1999 Aug 1;19(15):6385-93
references.pmid: 10414967
references.citation: Neurosci Lett. 2000 Sep 29;292(1):1-4
references.pmid: 10996435
references.citation: Exp Neurol. 2004 Nov;190(1):224-32
references.pmid: 15473995
references.citation: Annu Rev Pharmacol Toxicol. 2003;43:545-84
references.pmid: 12415125
references.citation: Biol Pharm Bull. 1997 Sep;20(9):958-61
references.pmid: 9331976
references.citation: BMC Neurosci. 2006 Nov 03;7:74
references.pmid: 17083736
references.citation: Life Sci. 2007 Aug 23;81(11):884-94
references.pmid: 17725929
references.citation: Neurosci Lett. 1999 Nov 12;275(2):152-4
references.pmid: 10568522
references.citation: J Neurochem. 2002 Aug;82(3):674-82
references.pmid: 12153491
references.citation: J Biol Chem. 1995 Oct 13;270(41):23895-8
references.pmid: 7592576
references.citation: Neuroscience. 2003;122(4):885-95
references.pmid: 14643758
references.citation: Neurobiol Aging. 1995 Jul-Aug;16(4):661-74
references.pmid: 8544918
references.citation: FASEB J. 2003 May;17(8):947-8
references.pmid: 12626428
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: Eur J Neurosci. 2000 Jun;12(6):1882-90
references.pmid: 10886329
references.citation: Mol Pharmacol. 2006 Jul;70(1):395-404
references.pmid: 16614138
references.citation: Neurosci Lett. 2006 May 15;399(1-2):57-60
references.pmid: 16483715
references.citation: Neurochem Res. 2004 Mar;29(3):637-50
references.pmid: 15038611
references.citation: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references.pmid: 6606682
references.citation: Biochem Biophys Res Commun. 1995 Nov 13;216(2):473-82
references.pmid: 7488136
references.citation: J Biol Chem. 2005 Mar 25;280(12):11615-25
references.pmid: 15659394
references.citation: Neurobiol Dis. 2004 Jun;16(1):21-8
references.pmid: 15207258
references.citation: Brain Res. 2000 Aug 11;873(2):235-42
references.pmid: 10930549
references.citation: Anal Biochem. 1979 Jun;95(2):351-8
references.pmid: 36810
references.citation: Neurology. 1995 Aug;45(8):1594-601
references.pmid: 7644059
references.citation: FEBS J. 2007 Feb;274(3):630-58
references.pmid: 17288551
references.citation: Recent Prog Horm Res. 2002;57:357-84
references.pmid: 12017552
references.citation: Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19114-9
references.pmid: 18025470
references.citation: Nature. 2006 Mar 16;440(7082):352-7
references.pmid: 16541076
references.citation: FASEB J. 2000 Jun;14(9):1202-14
references.pmid: 10834942
references.citation: Neuroscience. 2007 Jul 13;147(3):639-51
references.pmid: 17560726
references.citation: Neurosci Lett. 2001 Apr 13;302(1):58-62
references.pmid: 11278111
references.citation: Exp Neurol. 1998 Mar;150(1):40-4
references.pmid: 9514828
references.citation: Endocrine. 2007 Oct;32(2):206-11
references.pmid: 18064574
references.citation: FASEB J. 1995 Apr;9(7):526-33
references.pmid: 7737461
references.citation: J Psychiatry Neurosci. 2004 Nov;29(6):427-41
references.pmid: 15644984
references.citation: Am J Clin Nutr. 1995 Dec;62(6):1276-82
references.pmid: 7491892
references.citation: J Neurosci Res. 2001 Dec 1;66(5):873-84
references.pmid: 11746414
references.citation: J Neurochem. 2001 Aug;78(3):569-76
references.pmid: 11483660
references.citation: Anal Biochem. 1969 Mar;27(3):502-22
references.pmid: 4388022
references.citation: Brain Res. 2006 Aug 30;1107(1):192-8
references.pmid: 16828712
references.citation: Exp Neurol. 2001 Apr;168(2):385-91
references.pmid: 11259126
references.citation: Free Radic Biol Med. 2005 Jun 15;38(12):1604-13
references.pmid: 15917189
references.citation: Free Radic Biol Med. 2004 Jan 15;36(2):180-8
references.pmid: 14744630
references.citation: J Neurosci. 2003 Jun 15;23(12):5088-95
references.pmid: 12832532
references.citation: Free Radic Res. 2000 Nov;33(5):667-76
references.pmid: 11200097